Folgen
Annamária Kosztin MD, PhD, FESC
Annamária Kosztin MD, PhD, FESC
Semmelweis University
Bestätigte E-Mail-Adresse bei semmelweis.hu
Titel
Zitiert von
Zitiert von
Jahr
2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment …
TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ...
European Heart Journal 44 (37), 3627-3639, 2023
3352023
Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF
JJV McMurray, AM Jackson, CSP Lam, MM Redfield, IS Anand, J Ge, ...
Circulation 141 (5), 338-351, 2020
3282020
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ...
European heart journal 38 (9), 648-660, 2017
2242017
Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure …
O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ...
European journal of heart failure 21 (11), 1338-1352, 2019
2222019
In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry
G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ...
European journal of heart failure 19 (1), 54-65, 2017
1622017
Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ...
JACC: Heart Failure 6 (6), 452-462, 2018
1402018
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA …
P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ...
European journal of heart failure 22 (8), 1378-1389, 2020
1072020
Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score
M Tokodi, WR Schwertner, A Kovács, Z Tősér, L Staub, A Sárkány, ...
European heart journal 41 (18), 1747-1756, 2020
1012020
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
B Merkely, AJ Szabó, A Kosztin, E Berényi, A Sebestyén, C Lengyel, ...
Geroscience 42, 1063-1074, 2020
912020
Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ...
European journal of heart failure 22 (1), 92-102, 2020
832020
Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure …
V Kutyifa, L Geller, P Bogyi, E Zima, MK Aktas, EE Ozcan, D Becker, ...
European journal of heart failure 16 (12), 1323-1330, 2014
692014
Quantification of the relative contribution of the different right ventricular wall motion components to right ventricular ejection fraction: the ReVISION method
B Lakatos, Z Tősér, M Tokodi, A Doronina, A Kosztin, D Muraru, ...
Cardiovascular Ultrasound 15, 1-9, 2017
642017
Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial
B Merkely, A Kosztin, A Roka, L Geller, E Zima, A Kovacs, AM Boros, ...
Ep Europace 19 (9), 1549-1555, 2017
582017
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long …
A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ...
European Journal of Heart Failure 24 (2), 335-350, 2022
562022
De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis
A Kosztin, M Vamos, D Aradi, WR Schwertner, A Kovacs, KV Nagy, ...
Heart failure reviews 23, 15-26, 2018
502018
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry
CJ Kapelios, C Laroche, MG Crespo‐Leiro, SD Anker, AJS Coats, ...
European journal of heart failure 22 (8), 1424-1437, 2020
442020
Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration …
CJ Kapelios, M Lainscak, G Savarese, C Laroche, P Seferovic, ...
European journal of heart failure 21 (11), 1383-1397, 2019
432019
Contemporary management of severe symptomatic aortic stenosis
M Eugène, P Duchnowski, B Prendergast, O Wendler, C Laroche, ...
Journal of the American College of Cardiology 78 (22), 2131-2143, 2021
422021
Dominance of free wall radial motion in global right ventricular function of heart transplant recipients
BK Lakatos, M Tokodi, A Assabiny, Z Tősér, A Kosztin, A Doronina, ...
Clinical Transplantation 32 (3), e13192, 2018
372018
Role of right ventricular global longitudinal strain in predicting early and long-term mortality in cardiac resynchronization therapy patients
VK Nagy, G Széplaki, A Apor, V Kutyifa, A Kovács, A Kosztin, D Becker, ...
PloS one 10 (12), e0143907, 2015
362015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20